The CM2 Protein of Influenza C Virus Is an Oligomeric Integral Membrane Glycoprotein Structurally Analogous to Influenza A Virus M2and Influenza B Virus NB Proteins  by Pekosz, Andrew & Lamb, Robert A.
VIROLOGY 237, 439–451 (1997)
ARTICLE NO. VY978788
The CM2 Protein of Influenza C Virus Is an Oligomeric Integral Membrane Glycoprotein
Structurally Analogous to Influenza A Virus M2 and Influenza B Virus NB Proteins
Andrew Pekosz* and Robert A. Lamb*,†,1
*Howard Hughes Medical Institute and †Department of Biochemistry, Molecular Biology, and Cell Biology,
Northwestern University, Evanston, Illinois 60208-3500
Received July 11, 1997; returned to author for revision August 6, 1997; accepted August 13, 1997
We have undertaken a characterization of the CM2 protein of influenza C virus. The CM2 coding region of RNA segment
6 (nucleotides 731– 1147) was cloned from two strains of influenza C virus and expressed using the vaccinia virus-bacterio-
phage T7 RNA polymerase (vac-T7) system. An antiserum raised to a C-terminal peptide in the CM2 open reading frame
recognized the CM2 protein in influenza C virus-infected cells and after vac-T7 expression of the CM2 open reading frame.
CM2 is posttranslationally modified by addition of high-mannose carbohydrate chains (Mr 18 kDa) and by further addition
of polylactosaminoglycans (Mr 21–35 kDa). The available data indicate that CM2 has a cleavable signal peptide at the
N-terminus of the protein. Site-directed mutagenesis eliminated the single potential N-linked carbohydrate attachment site
on CM2 and indicated that the protein has an NoutCin orientation in membranes. Nonreducing SDS–PAGE indicated that the
protein was expressed as disulfide-linked dimers and tetramers. Cell surface biotinylation and indirect immunofluorescence
showed the protein to be expressed at the cell surface. Elimination of the N-linked carbohydrate attachment site and addition
of a C-terminal HA epitope tag did not adversely affect surface expression of CM2. The NoutCin membrane orientation of
CM2, the size of the ectodomain and cytoplasmic tail of CM2, and its ability to form disulfide-linked oligomers are reminiscent
of the structural properties of influenza A virus M2 and influenza B virus NB proteins. q 1997 Academic Press
INTRODUCTION which also encodes NA (Shaw et al., 1982, 1983). Both
M2 and NB are incorporated into virions as a third virion-Influenza A, B, and C viruses are biochemically related associated integral membrane protein, in addition to HA
although there are some major differences, the most and NA (Betakova et al., 1996; Brassard et al., 1996;
prominent of which is the fact that influenza A and B Hughey et al., 1995; Zebedee and Lamb, 1988). The M2
viruses both have a negative-stranded RNA genome con- protein of influenza A virus has an ion channel activity
sisting of eight RNA segments whereas the influenza C that is blocked by the antiviral drug amantadine (Pinto
virus genome consists of seven RNA segments. This et al., 1992; reviewed in Hay, 1992; Lamb et al., 1994).
difference is attributable to the fact that influenza A and B The M2 ion channel activity permits protons to enter viri-
viruses both encode, on separate RNA segments, distinct ons during the uncoating of particles in endosomes, as a
glycoproteins, hemagglutinin (HA) and neuraminidase low intravirion pH is required to weaken protein–protein
(NA), whereas influenza C virus encodes only a single interactions between the nucleocapsid (NP) and the ma-
glycoprotein that has hemagglutinating, esterase, and trix (M) protein (Bui et al., 1996; Zhirnov, 1992). The M2
fusion activities (HEF) (reviewed in Lamb and Krug, 1996). protein ion channel activity also functions to equilibrate
Influenza A and B viruses also encode, by distinctly pH between the lumen of the trans-Golgi network (TGN)
different mechanisms, small integral membrane proteins, and the cytoplasm which, for some strains of influenza
M2 (97 residues) and NB (100 residues), respectively, that A virus, is required to keep the HA above the threshold
have small extracellular domains (18–24 residues) and at which triggering of its conformational change to the
larger (54- to 60-residue) cytoplasmic tails (Lamb et al., low pH form would occur (Ciampor et al., 1992a,b; Gram-
1985; Williams and Lamb, 1986; Zebedee et al., 1985). bas et al., 1992; Grambas and Hay, 1992; Ohuchi et al.,
The M2 protein is encoded by a spliced mRNA derived 1994; Sugrue et al., 1990; Takeuchi and Lamb, 1994). It
from influenza A virus RNA segment 7 (Lamb et al., 1981), has been speculated that NB of influenza B virus is the
whereas the NB protein is encoded by a bicistronic functional counterpart of the influenza A virus M2 protein
mRNA derived from influenza B virus RNA segment 6, and that NB will have an ion channel activity based on
similarities in virus replication among influenza A and B
viruses (reviewed in Lamb and Pinto, 1997): reconstitu-1 To whom correspondence and reprint requests should be ad-
tion of Escherichia coli-expressed NB in planar bilayersdressed at Department of Biochemistry, Molecular Biology, and Cell
permitted the recording of an ion channel activity (Sun-Biology, Northwestern University, 2153 North Campus Drive, Evanston,
IL 60208-3500. Fax: (847) 491-2467. E-mail: ralamb@nwu.edu. strom et al., 1996).
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acid ORF has not been identified but in part this may
reflect the low steady-state level of the collinear mRNA
transcript (Hongo et al., 1994). Seven residues upstream
of the 5* splice site, the ORF contains three in-phase
AUG codons (nucleotides 731–733, 740–742, and 746–
748). For simplicity the ORF bounded by the AUG at
nucleotides 731–733 through the translational stop co-
don at nucleotides 1148–1150 has been designated
CM2 (Hongo et al., 1994) (Fig. 1A). The CM2 ORF contains
two hydrophobic domains, one of which is sufficiently
hydrophobic and long (23 residues) to span the mem-
brane and act as a transmembrane domain. A protein
designated CM2 (Mr 18 kDa) was immunoprecipitated
from influenza C virus-infected cells using an antiserum
raised against the CM2 ORF (Hongo et al., 1994). Consis-
tent with CM2 being an integral membrane protein, CM2
was found to be posttranslationally modified by glycosyl-
ation and acylation and to form oligomers of dimers and
tetramers, and preliminary data based on protease sensi-
tivity of CM2 suggested that it was expressed at the
surface of virus-infected cells. Analysis by immunoblot-
ting of virions subjected to rate zonal centrifugation sug-
gested that CM2 is a component of virions (Hongo et al.,
1997).FIG. 1. Schematic diagram of influenza C virus segment 6. (A) The
We have undertaken a characterization of the CM2M protein is translated from a spliced mRNA with an AUG (nucleotide
26) and a termination codon, TGA (nucleotide 752), which is present protein, when it is expressed in influenza C virus-infected
only in the spliced mRNA. The CM2 ORF is designated to begin at one cells and when it is expressed in cells using the vaccinia
of three in-frame AUG codons (nucleotides 731, 740, or 746) and it virus-bacteriophage T7 RNA polymerase (vac-T7) expres-
ends at nucleotide 1147. The CM2 coding region contains one potential
sion system, as a prerequisite to understanding the roleN-linked glycosylation site (oval), as well as domains resembling a
of CM2 in the influenza C virus life cycle. Our data confirmsignal peptide (SP), an N-terminal ectodomain (ECT), a hydrophobic
transmembrane domain (TM), and a C-terminal cytoplasmic tail (CYT). and extend the findings of Hongo and colleagues (1997).
(B) The complete amino acid sequence of CM2 from influenza C/Ann The CM2 ORFs from two isolates of influenza C virus
Arbor/1/50 virus (CM2AA) and the amino acid differences in CM2 from were cloned and expressed using the vac-T7 expression
influenza C/Taylor/1233/47 virus (CM2Tay). The putative signal peptide
system, and the available data indicate that CM2 con-is underlined with a solid line, the potential N-linked glycosylation site
tains a cleavable N-terminal signal sequence and formsis in boldface, the transmembrane domain is shaded, and the peptide
used to generate a-CM2 sera is underlined with a dotted line. disulfide-linked oligomers containing high-mannose car-
bohydrate chains that are subsequently modified by addi-
tion of polylactosaminoglycans. However, carbohydrate
moieties were not required for cell surface expressionA counterpart of a small integral membrane protein
encoded by influenza C virus did not appear to be en- as elimination of the N-linked glycosylation site did not
affect the expression pattern of CM2.coded by the genome. Of the seven RNA segments, only
the coding potential of RNA segment 6, which encodes
the viral matrix (M) protein (Yamashita et al., 1988), was MATERIALS AND METHODS
enigmatic. Whereas the nucleotide sequence of RNA
Cells and viruses
segment 6 indicated a single open reading frame (ORF)
of 374 residues, the M protein has a Mr of only 28 MDCK, HeLa-T4, and CV-1 cells were cultured in Dul-
becco’s modified Eagle’s (DME) medium, containing 10%kDa. Examination of the nature of the mRNAs found in
influenza C virus-infected cells indicated that there was fetal bovine serum (FCS), 2 mM glutamine, and penicillin/
streptomycin (P/S). Influenza C/Taylor/1233/47 and C/a small amount of an mRNA collinear with RNA segment
6 but in addition, there was a spliced mRNA, and elimina- Ann Arbor/1/50 viruses were obtained from Dr. Nancy
Cox (Influenza Branch, Centers for Disease Control, At-tion of the intron (nucleotides 754–981) caused the intro-
duction of a termination codon into the RNA segment 6 lanta, GA). Seed stocks were established by infecting
MDCK monolayers with virus for 2 hr at 377 in the pres-ORF after amino acid residue 242 (Hongo et al., 1994;
Yamashita et al., 1988) (Fig. 1A). Thus, this truncated ence of N-acetyl trypsin (5 mg/ml). The inoculum was
removed and the cells were incubated in DME with gluta-ORF is compatible with encoding the influenza C virus
M protein. A protein derived from the entire 374-amino- mine, P/S, and N-acetyl trypsin (5 mg/ml) at 337. A cyto-
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pathic effect was clearly evident in the infected mono- In vitro transcription and translation
layers at 7 days postinfection (p.i.), at which time super-
T7 RNA polymerase transcripts were made from Hindnatants were harvested, clarified by centrifugation, and
III linearized pGEM3-CM2AAtag as previously describedstored at 0707. Infectious virus titer was determined by
(Paterson and Lamb, 1993). RNA was translated in theplaque assay on MDCK cells and by hemagglutination
presence of [35S]-Pro-mix (30 mCi) (Amersham Life Sci-titer with 0.5% chick red blood cells, essentially as de-
ence, Arlington Heights, IL) using the methionine-de-scribed for influenza A virus (Paterson and Lamb, 1993).
pleted wheat germ extract system (Promega Corp., Madi-Virus working stocks were prepared by infecting MDCK
son, WI) and proteins immunoprecipitated with mono-cells at a multiplicity of infection (m.o.i.) of 0.01 plaque-
clonal antibody 12CA5 (specific for C-terminal HAforming units (PFU) per cell for 2 hr at 337, removing the
epitope tag) and polypeptides analyzed by SDS–PAGE.inoculum, and culturing the cells in DME with glutamine,
P/S, and N-acetyl trypsin (5 mg/ml) at 337 until a cyto-
Antiserum productionpathic effect was evident throughout the culture. The su-
pernatants were then collected, clarified by low-speed CM2-specific serum was generated against a syn-
centrifugation, aliquoted, and stored at 0707. thetic peptide (NH2-CRERLDLGEDAPDETDISPI-COOH)
corresponding to amino acids 111–129 of CM2. The pep-
tide (5 mg) was coupled to keyhole limpet hemocyaninPlasmid construction, epitope tagging and site-
(KLH, Pierce, Rockford, IL) (5 mg) by incubation in 0.1directed mutagenesis
M phosphate buffer, pH 8.0, containing the crosslinking
reagent Sulfo-SMCC (25 mM, Pierce Chemical Co., Rock-The nucleotide numbering used in this paper is based
ford, IL) for 2 hr at room temperature. The peptide–KLHon the published sequence for influenza C/Ann Arbor/1/
complexes were loaded onto a PD-10 gel filtration col-50 virus (Yamashita et al., 1988) and differs from that of
umn (Pharmacia Biotech) and eluted in 0.1 M phosphateHongo and colleagues (1994) by01 nucleotide. RNA was
buffer, pH 7.1, and protein concentration was determinedobtained from influenza C virus-infected cell superna-
by BCA assay (Pierce). Antiserum was produced in rab-tants by SDS–phenol extraction and ethanol precipitation
bits (Covance Research Products, Denver, PA).(Paterson and Lamb, 1993). Reverse transcription was
performed on 0.5 mg of viral RNA, with avian myelo-
Infection, transfection, and metabolic labeling of cellsblastosis virus reverse transcriptase (Pharmacia Biotech,
Piscataway, NJ), according to the manufacturer’s recom- Nearly confluent monolayers of MDCK cells were in-
mended conditions, and a primer specific for the influ- fected with influenza C virus at an m.o.i. of 5–10 for 2 hr
enza C/Ann Arbor/1/50 virus segment 6 RNA nucleotides at 377. The inoculum was removed and the cells were
20–41 (Yamashita et al., 1988). The entire segment 6 then cultured at 377 in DME with glutamine and P/S for
coding region was amplified by polymerase chain reac- the indicated times.
tion (PCR), using Vent DNA polymerase (New England For expression of cloned CM2, the vac-T7 expression
Biolabs, Beverley, MA) and primers (corresponding to system was used, essentially as described previously
nucleotides 20–41 and 1153–1174) containing unique (Fuerst et al., 1986). Briefly, HeLa-T4 or CV-1 cells in
restriction enzyme sites for cloning into pGEM3. The 3.5-cm-diameter tissue culture plates were infected with
CM2 ORF from influenza C/Taylor/1233/47 (CM2Tay) or vTF7.3, a vaccinia virus expressing the bacteriophage T7
influenza C/Ann Arbor/1/50 (CM2AA) was cloned by PCR RNA polymerase, at an m.o.i. of 10 in OptiMEM (Gibco
with Vent DNA polymerase and primers corresponding Life Technologies, Grand Island, NY) with 0.1% bovine
to nucleotides 725–745 and 1153–1174 of segment 6. serum albumin (BSA), for 1 hr at 377. Plasmids were
Addition of the epitope for monoclonal antibody (mAb) transfected using liposomes made in our laboratory
12CA5 (Wilson et al., 1984) at the C-terminus of CM2AA (Rose et al., 1991), and the cells were incubated for an
(CM2AAtag) was accomplished by PCR using a primer additional 4 hr post transfection (pt) at 377. For pulse–
containing the amino acid coding sequence for the epi- chase labeling, the cells were incubated for 30 min with
tope in frame with the CM2 coding sequence and in DME deficient in methionine and cysteine (Met0 Cys0
place of the naturally occurring stop codon for CM2. The DME), containing 20 mM HEPES, pH 7.1, glutamine, and
unique site elimination (USE) mutagenesis kit (Phar- P/S. Cultures were labeled metabolically by replacing
macia Biotech, Piscataway, NJ) was used to generate a the medium with Met0 Cys0 DME containing 20 mM
threonine-to-alanine change at amino acid 37 in the ORF HEPES, pH 7.1, glutamine, P/S and containing [35S]-Pro-
of CM2AA and CM2AAtag, creating the glycosylation site mix (50 mCi per well for vac-T7 expression or 100 mCi
knockout mutants, CM2AAT37A and CM2AAtagT37A, re- per well for influenza C virus-infected cells) for 15 min
spectively. All plasmids were sequenced using an ABI at 377. The chase periods were initiated by replacing the
Prism 310 genetic analyzer (Applied Biosystems Inc., medium with chase medium (DME with glutamine and
P/S) and cells were incubated at 377 for various times.Foster City, CA).
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Cell monolayers were lysed in RIPA buffer (10 mM Tris, Indirect immunofluorescence
pH 7.4, 1% deoxycholate, 1% Triton X-100, 0.1% SDS)
CV-1 cells on glass coverslips were infected withcontaining 50 mM iodoacetamide and protease inhibitors
vTF7.3, transfected with 2.5 mg plasmid DNA per 3.5-cm-(Paterson and Lamb, 1993). The lysates were clarified by
diameter tissue culture plate, and incubated for 6 hr atcentrifugation for 10 min at 55,000 rpm in a Beckman
377. All subsequent steps were performed at room tem-TLA100.2 rotor and stored at 0707.
perature. Cell monolayers were washed twice with PBS,
fixed in 4% paraformaldehyde for 10 min, and permeabil-Immunoprecipitation and glycosidase treatment
ized with PBS containing 0.2% Triton X-100 for 10 min.
Cell lysates were incubated with a-CM2 rabbit serum After washing with PBS, a blocking solution of PBS with
or mAb 12CA5 (both at final dilutions of 1:100) for 3 hr 5% normal goat serum (NGS, Sigma Chemical Co., St.
at 47, after which the immune complexes were isolated Louis, MO) and 0.1% BSA was added for 30 min. The
by incubating with protein A–Sepharose for 1 hr at 47. monoclonal antibody 12CA5 was added at a final dilution
The samples were washed three times with RIPA buffer of 1:1000 in blocking solution and incubated for 1 hr. The
containing 0.3 M NaCl, once with RIPA buffer containing cells were washed with PBS, before addition of FITC-
0.15 M NaCl, and finally with 50 mM Tris, pH 7.4, 0.25 conjugated goat anti-mouse IgG (Jackson ImmunoRe-
mM EDTA, 0.15 M NaCl before resuspension in SDS – search Laboratories, Inc., West Grove, PA) at a final dilu-
PAGE loading buffer. Proteins were analyzed by SDS – tion of 1:500 in blocking solution for 30 min. After washing
PAGE. To determine the nature of the carbohydrate modi- with PBS, the coverslips were mounted onto glass slides
fications of CM2, lysates were immunoprecipitated as using FITC-guard (Testog Inc., Chicago, IL) and exam-
above and then digested for 16 hr at 377 with peptide- ined on a Zeiss LSM 410 confocal microscope (Carl Zeiss
N-glycosidase F (PNG), endoglycosidase H (endo H), or Inc., Thornwood, NY).
endo b galactosidase (endo b) (all from Boehringer-
Mannheim Corp., Indianapolis, IN). Samples were then RESULTS
boiled in SDS–PAGE sample buffer and polypeptides
analyzed by SDS–PAGE. Cloning and identification of CM2
To investigate the properties of CM2, RNA segment 6SDS–PAGE
and CM2 ORF were cloned from vRNA. DNA primers
Polypeptides were analyzed on 15% acrylamide or were designed using the known nucleotide sequence
17.5% acrylamide containing 4 M urea gels, as described of RNA segment 6 of influenza C/Ann Arbor/1/50 virus
previously (Paterson and Lamb, 1993). 14C-labeled Mr (Yamashita et al., 1988) to permit isolation of the entire
standards (Amersham Life Sciences) were loaded on coding region of RNA segment 6 and the CM2 ORF. Viral
gels to approximate molecular weights. The gels were RNA from influenza C virus strains C/Ann Arbor/1/50 (AA)
fixed, treated with Amplify (Amersham Life Sciences), and and C/Taylor/1233/47 (Tay) was used to generate RT-
then dried before exposure to X-OMAT AR (Eastman Ko- PCR fragments that were subsequently cloned into
dak Co., Rochester, NY) film at 0707. pGEM3, and the nucleotide sequence of the entire insert
was determined.
Cell surface biotinylation, Western blotting, and
The nucleotide sequence obtained for the CM2 ORF of
biotinylated protein detection
C/Ann Arbor/1/50 (CM2AA) predicts two amino acid
changes (Fig. 1B) from the amino acid sequence deter-Cell surface protein expression was detected essen-
tially as described (Leser et al., 1996). Briefly, cells were mined previously (Hongo et al., 1994): a Thr-to-Asn change
at amino acid residue 48 (which eliminates a second poten-placed at 47 for 10 min, and all subsequent steps were
performed at that temperature. After washing with PBS, tial glycosylation site in CM2AA) and an Ile-to-Asn change
at amino acid residue 126. The CM2 proteins from severalthe cells were incubated twice for 15 min with freshly
diluted NHS-LC-biotin (Pierce) (0.3 mg/ml) in PBS. The isolates have similar mobilities and for all other isolates
only one N-linked glycosylation site is predicted. As an Asnreaction was quenched by incubating the cells in PBS
with 50 mM glycine for 10 min. Cell monolayers were is found at residue 126 in all other isolates of influenza C
virus (Hongo et al., 1994), it seems likely that the only truelysed with RIPA buffer, proteins were immunoprecipi-
tated, and polypeptides were analyzed by SDS–PAGE amino acid difference between CM2AA and CM2Tay is a
Cys for Tyr substitution at residue 14.and transferred to PVDF membranes (Paterson and
Lamb, 1993). Biotinylated proteins were detected with The predicted amino acid sequence of the CM2 ORF
(Fig. 1B) indicates that there are two hydrophobic do-the streptavidin-alkaline phosphatase conjugate Avidx-
AP and the chemiluminescent substrate CSPD (both from mains. The first hydrophobic region, residues 6–17, has
the hallmarks of a cleavable signal sequence for tar-Tropix, Inc., Bedford, MA), according to the manufactur-
er’s protocol. The membranes were exposed to X-OMAT geting the protein to the endoplasmic reticulum (ER)
membrane, as the core hydrophobic region is followedLS film (Eastman Kodak Co.) for 10–30 min.
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FIG. 2. Expression of CM2 from cDNA and in influenza C virus-infected cells. (A) HeLa-T4 cells were infected with vac-T7 and transfected with
plasmids encoding CM2AAtag, CM2AA, or CM2Tay. At 4 hr pt the cells were pulse-labeled for 15 min with [35S]-Pro-mix (50 mCi/plate) and incubated
for 1 hr in chase medium; the cells were lysed and proteins immunoprecipitated using a rabbit serum generated to a CM2 peptide (a-CM2), or
with preimmune sera. Polypeptides were analyzed by SDS–PAGE on 17.5% acrylamide gels containing 4 M urea and processed for fluorography.
The a-CM2 sera recognized an 18-kDa protein encoded by the CM2 ORF of influenza C/Taylor/1233/47 virus (CM2Tay) and C/Ann Arbor/1/50
virus (CM2AA), as well as the slightly larger, HA epitope-tagged CM2AA (CM2AAtag). The preimmune serum did not immunoprecipitate any of the
proteins. (B) Influenza C/AA/1/50 virus-infected cells (m.o.i. of 5) were incubated in DME supplemented with N-acetyl trypsin (5 mg/ml) for the
indicated times. The cells were pulse-labeled with [35S]-Pro-mix (100 mCi/plate) for 15 min and incubated in chase medium for 1 hr; cells were
lysed, proteins were immunoprecipitated, and polypeptides were analyzed by SDS–PAGE on 17.5% acrylamide gels containing 4 M urea. The a-
CM2 sera immunoprecipitated 15- and 18-kDa proteins, as well as heterogeneously migrating species ranging in size from 21 to 35 kDa
which are not found in mock-infected cells. Mr standards are indicated at the left of the gels.
by an Ala at residue 24 and this residue is in a good Influenza C virus-infected cells at various times p.i. were
amino acid context for cleavage by signal peptidase (von metabolically labeled with [35S]-Pro-mix, and cell lysates
Heijne, 1986). The second hydrophobic region (residues were immunoprecipitated with the a-CM2 serum (Fig. 2B).
48–70) may serve as a transmembrane domain. Three distinct polypeptide species, not found in uninfected
To identify the CM2 protein, a rabbit serum to a peptide cells, were immunoprecipitated from virus-infected cells:
derived from amino acid residues 111–129 was gener- an 18-kDa band, an 15-kDa band and a very heteroge-
ated. The nucleotides encoding an epitope tag for mAb neous species of Mr 21–35 kDa. The two smaller poly-
12CA5 (NH2-YPYDVPDYA-COOH) were inserted into the peptides appeared identical to those observed on expres-
cDNA by PCR immediately before the termination codon sion of CM2AA from cDNA, while the electrophoretic mobil-
of CM2, resulting in a protein (CM2AAtag) containing this ity of the 21- to 35-kDa species was reminiscent of the
epitope as the final nine amino acids of the ORF. polylactosaminoglycan modifications found on NB protein
CM2AA, CM2AAtag, or CM2Tay was expressed using of influenza B virus (Williams and Lamb, 1988).
the vac-T7 expression system and was metabolically la-
beled with [35S]-Pro-mix. Proteins were immunoprecipi- Identification of a signal peptide and an N-linked
tated with the antipeptide serum or preimmune serum glycosylation site and determination of the membrane
(Fig. 2A). The a-CM2 serum recognized an18-kDa poly- orientation of CM2
peptide (glycosylated CM2, see below) and a much less
Sequence analysis of the CM2AA ORF shows only onepredominant15-kDa polypeptide (unglycosylated CM2,
potential N-linked glycosylation site (Asn-X-Thr) at aminosee below) from CM2AA- and CM2Tay-transfected cells,
acid 35. To demonstrate that this site was utilized, site-as well as an 21-kDa polypeptide from CM2AAtag-
specific mutagenesis was used to introduce the substitu-transfected cells. The preimmune serum did not immuno-
precipitate detectable proteins from any of the lysates. tion of alanine for the threonine residue at amino acid 37
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translated in vitro using wheat germ extracts and the
[35S]-Pro-mix-labeled proteins were immunoprecipitated
using the C-terminal tag-specific mAb 12CA5. The elec-
trophoretic mobility of the protein synthesized in vitro
was compared to CM2AAtag expressed in HeLa-T4 cells.
As shown in Fig. 4, the in vitro translated CM2AAtag
had a slower mobility than CM2AAtag that had been
expressed in vivo and PNG-treated, indicating that CM2
synthesized in vitro contained additional amino acid resi-
dues. Furthermore, since both polypeptides were immu-
noprecipitated with mAb 12CA5, which recognized the
inserted epitope at the C-terminus of CM2AAtag, the ad-
ditional amino acids must be present at the N-terminus
of the polypeptide. Thus, these data suggest that CM2
has a cleavable signal peptide.
Nature of the carbohydrate modifications
To characterize the nature of the CM2 carbohydrate
modifications, HeLa-T4 cells expressing CM2AA or
CM2AAtag were pulse-labeled for 15 min with [35S]-Pro-
mix and incubated in chase medium for 0 or 3 hr. As
FIG. 3. The N-terminus of CM2 contains an N-linked glycosylation shown in Fig. 5A, a relatively discrete band was present
site. Site-directed mutagenesis eliminated a putative N-linked glycosyl-
at 0 hr, which was converted to a heterogeneously mi-ation site (Asn-X-Thr) by changing amino acid 37 of the CM2 ORF from
Thr to Ala in CM2AA and CM2AAtag. Wild-type and mutant proteins
were expressed in HeLa-T4 cells using the vac-T7 expression system
and transfection of 2.5 mg plasmid DNA per 3.5-cm-diameter plate. At
4 hr pt the cells were metabolically pulse-labeled with [35S]-Pro-mix
(50 mCi/plate) and incubated in chase medium for 1 hr; cells were
lysed, and proteins were immunoprecipitated and digested with PNG
to remove N-linked carbohydrate modifications. Polypeptides were ana-
lyzed by SDS–PAGE on 17.5% acrylamide gels containing 4 M urea.
Changing residue 37 from Thr to Ala by site-specific mutagenesis re-
sulted in a protein which comigrated with the corresponding PNG-
treated CM2 and whose mobility was not changed after treatment
with PNG, indicating a loss of carbohydrate modifications in proteins
expressed from the mutant plasmids.
in both CM2AA and CM2AAtag. The resulting plasmids
(designated CM2AAT37A and CM2AAtagT37A) were ex-
pressed by using the vac-T7 expression system. The
cells were labeled with [35S]-Pro-mix and proteins were
immunoprecipitated with a-CM2 serum and treated with
PNG to investigate the addition of N-linked carbohydrate
chains. PNG treatment of CM2AA and CM2AAtag caused
the polypeptide species to migrate faster on gels (Fig.
3), indicating the addition of N-linked carbohydrate to
CM2AA and CM2AAtag. In contrast the proteins con-
taining the T37A mutation had the same gel mobility with
or without PNG treatment and migrated identically to
FIG. 4. Evidence that CM2 contains a cleaved, N-terminal signal
PNG-treated wild-type protein, indicating that the Asn peptide. The CM2AAtag cDNA (containing the C-terminal HA epitope
residue at amino acid 35 is used for the addition of carbo- tag) was transcribed using bacteriophage T7 RNA polymerase and the
RNA was subsequently translated in vitro using wheat germ extracthydrates to CM2. As N-linked carbohydrate chains are
and [35S]-Pro-mix. Proteins were immunoprecipitated with mAb 12CA5added to glycoproteins in the lumen of the ER, the addi-
and polypeptides analyzed by SDS–PAGE on 17.5% acrylamide gelstion of carbohydrate to Asn residue 35 indicates that
containing 4 M urea. The in vitro translated protein displayed a slower
CM2 is oriented with a lumenal N-terminal domain. mobility on SDS–PAGE than in vivo expressed CM2AAtag that had
Evidence for the presence of a cleavable N-terminal been treated with PNG, indicating the presence of additional amino
acids at the amino-terminus of the in vitro translated protein.signal peptide on CM2 was sought. CM2AAtag was
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FIG. 5. CM2 expressed from cDNA or in influenza C virus-infected cells contains high-mannose and polylactosaminoglycan carbohydrates. (A)
CM2AA and CM2AAtag cDNAs were expressed in HeLa-T4 cells using the vac-T7 expression system. Plasmids (2.5 mg DNA per 3.5-cm-diameter
plate) were transfected, and the cells were incubated for 4 hr before metabolical labeling with [35S]-Pro-mix (50 mCi/plate) for 15 min, followed by
incubation in chase medium for 0 or 3 hr. Cells were lysed, proteins were immunoprecipitated with a-CM2 serum, polypeptides were analyzed on
17.5% acrylamide containing 4 M urea, and the gels were processed for fluorography. (B) CM2AA was metabolically labeled as in (A) and incubated
in chase medium for 3 hr. Immunoprecipitated polypeptides were digested with endo H, PNG, or endo b before analysis by SDS–PAGE and
fluorography. (C) At 18 hr p.i. influenza C virus-infected MDCK cells were metabolically labeled with [35S]-Pro-mix (100 mCi per plate) for 15 min
and incubated in chase medium for 0 or 3 hr. The cells were lysed, and proteins were immunoprecipitated and digested with the indicated
glycosidases before analysis by SDS–PAGE and fluorography. The CM2 glycoprotein contains both high mannose and polylactosaminoglycan
carbohydrates. CM2(pl) , polylactosaminoglycan containing CM2; CM2(18) , 18-kDa form of CM2; CM2(15) , 15-kDa form of CM2.
grating species of slower electrophoretic mobility after converted to a heterogeneous, higher molecular weight
species (Mr 21–35 kDa) (Fig. 5C). CM2 expressed inincubation in chase medium for 3 hr and the amount of
the heterogeneously migrating species was greater after influenza C virus-infected cells had a glycosidase sensi-
tivity profile similar to that expressed using the vac-T7a 3-hr chase period than after a 1-hr chase period (cf
Fig.2). After the 3-hr chase period, CM2AA was digested expression system (Fig. 5C); the 18-kDa band was
endo H sensitive, the 21- to 35-kDa species were endowith endoglycosidase H (endo H), peptide N glycanase
(PNG), or endo b galactosidase (endo b). As shown in b sensitive, and all forms were PNG sensitive, indicating
that the carbohydrates are N-linked. Thus, these dataFig. 5B, PNG treatment collapsed all of the CM2AA spe-
cies to the 15-kDa, unglycosylated form. The 18-kDa indicate that CM2 contains high-mannose carbohy-
drates, a portion of which are further modified by additionband was the only species susceptible to endo H diges-
tion, suggesting that the 18-kDa species represents of polylactosaminoglycans.
CM2 containing a single high-mannose carbohydrate
chain. Endo b digestion converted virtually all of the high- Oligomeric nature of CM2
molecular-weight heterogeneous species to a species
of 18 kDa, indicating that the carbohydrate chains of To examine intermolecular disulfide bond formation,
CM2 are modified by the addition of polylactosaminogly- CM2AA, CM2AAtag, CM2AAT37A, and CM2AAtagT37A
cans. were expressed using the vac-T7 expression system.
To examine if the carbohydrate modifications found Cultures were metabolically labeled with [35S]-Pro-mix
on CM2 were the same when CM2 was expressed in and polypeptides analyzed on SDS–PAGE under nonre-
influenza C virus-infected cells as when expressed using ducing conditions. As shown in Fig. 6, both CM2AA and
the vac-T7 expression system, influenza C/AA virus-in- CM2AAtag migrated primarily as species corresponding
fected MDCK cells at 18 hr p.i. were metabolically labeled to dimers (Mr 38 kDa for CM2AA and Mr 42 kDa for
and incubated in chase medium for 0 or 3 hr. At 0-hr CM2AAtag) and tetramers (Mr 64 kDa for CM2AA and
chase, CM2 was observed as a discrete 18-kDa spe- Mr85 kDa for CM2AAtag). Other oligomeric forms were
detectable, perhaps due to the odd number of cysteinescies but after a 3-hr chase period, much of CM2 was
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gestion) was labeled with biotin, indicating CM2 expres-
sion at the surface of virus-infected cells. As a control
for surface biotinylation and to rule out internal cell label-
ing, the cell lysates were also immunoprecipitated with
a ferret a-influenza C/AA serum, which detected biotinyl-
ated HEF protein but not the internal NP protein, even
though the serum was capable of recognizing NP when
used to immunoprecipitate [35S]-Pro-mix labeled NP from
cell lysates (Fig. 7B).
Effect of CM2 expression level on CM2 glycosylation
When CM2 was expressed by using the vac-T7 expres-
sion system, it was observed that CM2 was found in
a form with a greater preponderance of high-mannose
carbohydrate chains, whereas CM2 expressed in influ-
enza C virus-infected cells was found predominantly to
be further modified by polylactosaminoglycans (cf. Figs.
2A and 2B). To determine the possible effect of CM2
expression level on the amount of CM2 polylactosami-
noglycan addition, the amount of CM2 plasmid DNA
FIG. 6. CM2 is present as disulfide-linked oligomers. CM2AA, transfected was titrated, keeping the total amount of DNA
CM2AAtag, CM2AAT37A, and CM2AAtagT37A were expressed using
constant with pGEM3 DNA. With low CM2 expressionthe vac-T7 system (2.5 mg plasmid DNA per 3.5-cm-diameter plate of
levels, CM2 contained predominantly a polylactosami-HeLa-T4 cells). The cells were metabolically labeled with [35S]-Pro-mix
(50 mCi/plate for 15 min), incubated for 1 hr in chase medium, and noglycan modification, whereas with increasing CM2 ex-
lysed, and the proteins were immunoprecipitated with a-CM2 rabbit pression levels, the amount of this modification was
serum and polypeptides were analyzed by SDS–PAGE under nonre- greatly reduced, resulting in the expression of only the
ducing conditions on 17.5% acrylamide gels containing 4 M urea. With 18-kDa high mannose-containing form and the 15-all proteins, the predominant species were dimers and tetramers, but
kDa unglycosylated CM2 form (Fig. 8).other oligomeric forms were also detected. The absence of N-linked
carbohydrates modification had no discernible effect on oligomer for-
mation. D, dimer; T, tetramer. Surface expression of CM2 using the vac-T7 system
To investigate if overexpression of CM2 blocked its
own accumulation at the cell surface, CM2AA, CM2AA-in the ectodomain of CM2AA (see Fig. 1B) and inappropri-
ate disulfide bond formation. The T37A glycosylation mu- tag, and the corresponding glycosylation minus, T37A
mutants were expressed by using the vac-T7 expressiontants also showed an oligomeric pattern similar to the
corresponding glycosylated proteins, suggesting that the system, and cell surface biotinylation was performed. As
shown in Fig. 9, CM2 in its endo H-sensitive form waslack of glycosylation does not affect the oligomeric nature
of the protein (Fig. 6). biotinylated, indicating that transport to the cell surface
was not completely blocked. Furthermore, the glycosyla-
Surface expression of CM2 in influenza C virus- tion minus T37A mutants were also biotinylated, indicat-
infected cells ing that carbohydrate modifications are not required for
transport of CM2 to the cell surface.To determine if CM2 is expressed at the cell surface,
biotinylation of intact cells expressing CM2 was per-
Indirect immunofluorescence of vac-T7-expressed
formed, as an antiserum specific to the ectodomain of
CM2AAtag and CM2AAtagT37A
CM2 has not been generated. Influenza C/AA virus-in-
fected MDCK cells at 18 hr p.i. or mock-infected cells The cellular expression of CM2AAtag and CM2AA-
tagT37A was determined by indirect immunofluores-were treated with NHS-LC-biotin to label cell surface
proteins. The cells were lysed, proteins were immunopre- cence. The HA epitope-tagged molecules were used for
this experiment due to a lack of specific reactivity ofcipitated, and polypeptides were analyzed by SDS –
PAGE. The polypeptides were transferred to PVDF mem- the a-CM2 rabbit serum in this assay. CM2AAtag- and
CM2AAtagT37A-expressing cells at 6 hr pt were fixedbranes, and biotinylated proteins were detected by incu-
bating the membrane with streptavidin conjugated to al- with paraformaldehyde and permeabilized with PBS con-
taining 0.2% Triton X-100 (to allow detection of the C-kaline phosphatase followed by addition of a chemilumi-
nescent substrate. terminal HA epitope). The cells were stained with mAb
12CA5 and FITC-conjugated goat anti-mouse IgG beforeAs shown in Fig. 7A, CM2 modified by addition of
polylactosaminoglycan (note its sensitivity to endo b di- examination by confocal microscopy. A Z-series cross-
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FIG. 7. CM2 is expressed at the cell surface of influenza C virus-infected cells. (A) Influenza C virus-infected or mock-infected MDCK cells at 18 hr p.i.
were surface biotinylated. Proteins were immunoprecipitated with rabbit a-CM2 serum or ferret a-influenza C/Ann Arbor/1/50 serum (a-C/AA) and treated
with endo b or PNG as indicated, and polypeptides were analyzed by SDS–PAGE on 15% acrylamide gels. Polypeptides were transferred to PVDF
membranes for detection of biotin using streptavidin-conjugated alkaline phosphatase. CM2 is biotinylated, indicating its presence at the cell surface. (B)
Mock- or influenza C virus-infected MDCK cells at 18 hr p.i. were metabolically labeled with [35S]-Pro-mix for 15 min and incubated in chase medium for
1 hr, cells were lysed, and proteins were immunoprecipitated with the indicated antisera. The immunoprecipitated polypeptides were separated by SDS–
PAGE on 15% acrylamide gels and processed for fluorography. The ferret a-C/AA recognizes both HEF and NP from influenza C virus-infected cells,
while it does not immunoprecipitate CM2. CM2(pl) , polylactosaminoglycan-modified CM2; HEF, hemagglutinin, esterase, fusion protein; NP, nucleoprotein.
sectioning of cells was performed, beginning at the cell ase digestion and the relative resistance of CM2 on cell
surface and proceeding through the cell. The expression surfaces to protease digestion, were interpreted to indi-
patterns for CM2Aatag and CM2AAtagT37A were found cate that CM2 had a NoutCin orientation in membranes
to be quite similar. The staining pattern of sections at (Hongo et al., 1997).
the outer periphery of the cell (Figs. 10A and 10B) is Here we have demonstrated that CM2 is encoded
consistent with expression of CM2 at the cell surface. within the CM2 ORF (nucleotides 731–1147) on influenza
No FITC staining was detected in cells transfected with C virus RNA segment 6. The CM2 N-terminal hydrophobic
pGEM3 alone (Fig. 10C) or without first permeabilizing domain is most likely a signal sequence, as the differ-
the cells with detergent (data not shown). ence in gel mobility between the larger CM2 synthesized
in vitro and the smaller deglycosylated CM2 synthesized
DISCUSSION in vivo (which had the same mobility as unglycosylated
CM2 synthesized in the presence of tunicamycin; ourA polypeptide designated CM2 (Mr18 kDa) had been
unpublished observation) is to be expected for the pres-identified previously (Hongo et al., 1994) and it was found
ence of a cleavable signal sequence. From von Heijne’sin cells infected with several isolates of influenza C virus
(1986) algorithm it can be deduced that cleavage of the(Hongo et al., 1997). A precursor product relationship
signal sequence is most likely to occur after Ala residuewas demonstrated between the 18-kDa CM2 species
24; thus, the mature CM2 polypeptide chain is predictedand a heterogeneously migrating CM2 species (Mr21 –
to contain 115 residues. Mutagenesis to ablate addition35 kDa). Although the 18-kDa CM2 species was sus-
of N-linked glycosylation to Asn residue 35 and the find-ceptible to endo H digestion, indicating the presence of
ing that the altered protein had a faster gel electropho-high-mannose carbohydrate chains, the heterogeneously
retic mobility than wild-type CM2, but had an equivalentmigrating 21- to 35-kDa species could not be digested
gel mobility to that of CM2 after digestion with PNG,with endo b, suggesting that the carbohydrate modifica-
indicated that Asn residue 35 is modified by the additiontion was not an addition of simple polylactosaminoglycan
of N-linked carbohydrate. Attachment of carbohydrate to(Hongo et al., 1997). It was also found that CM2 formed
residue 35 also adds support to the notion that one ofdisulfide-linked dimers and tetramers. Preliminary data,
based on the sensitivity of CM2 in microsomes to prote- the three AUG codons prior to the first hydrophobic do-
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FIG. 8. Increased expression of CM2 reduces polylactosaminoglycan
modifications of the N-linked carbohydrate chain. CM2 was expressed
in HeLa-T4 cells using the vac-T7 expression system. Increasing
amounts of CM2AA plasmid DNA (0, 0.005, 0.01, 0.025, 0.05, 0.1, 0.25,
0.5, and 1.0 mg DNA) were transfected per 3.5-cm-diameter plate, with
the total amount of DNA being kept constant at 2.5 mg by the addition
of pGEM3 DNA. Cells were metabolically labeled with [35S]-Pro-mix (50
mCi/plate) for 15 min, incubated in chase medium for 1 hr, and lysed.
Proteins were immunoprecipitated with a-CM2 serum and polypeptides
analyzed by SDS–PAGE on 17.5% acrylamide with 4 M urea. Low
concentrations of CM2 plasmid resulted in more polylactaminoglycan-
modified glycoprotein, while higher concentrations of plasmid resulted
in the synthesis of high-mannose-containing CM2 glycoprotein.
main on CM2 is used to initiate CM2 synthesis, as these
are the first AUG residues before CM2 residue 35. It is
noted that by Kozak’s rules the first AUG codon is in
the strongest context for initiation of protein synthesis
(Kozak, 1989).
FIG. 10. Indirect immunofluorescence for surface expression of
CM2AAtag and CM2AAtagT37A. CV-1 cells were plated on glass cov-
erslips, infected with vac-T7, transfected with 2.5 mg DNA encoding (A)
CM2AAtag, (B) CM2AAtagT37A, or (C) pGEM3 per 3.5-cm-diameter
plate, and incubated for 6 hr pt. The cells were fixed with paraformalde-
hyde, permeabilized with 0.2% Triton X-100 (to allow detection of the C-
FIG. 9. CM2 containing high-mannose carbohydrates is expressed terminal HA epitope tag), and analyzed by indirect immunofluorescence
at the cell surface. Proteins were expressed in HeLa-T4 cells using with mAb 12CA5. The samples were examined by confocal microscopy.
the vac-T7 expression system. Cells were transfected with 2.5 mg DNA CM2AAtag and CM2AAtagT37A showed very similar surface expres-
encoding CM2AA, CM2AAtag, CM2AAT37A, or CM2AAtagT37A per 3.5- sion patterns. Arrows indicate staining at the plasma membrane.
cm-diameter plate and incubated for 4 hr before cell surface biotinyla-
tion. The cells were lysed, and proteins were immunoprecipitated with
a-CM2 serum and treated with endo H as indicated. Polypeptides were As we found that the heterogeneously migrating CM2
analyzed by SDS–PAGE on 15% acrylamide gels, transferred to PVDF species (Mr 21–35 kDa) can be digested by endo b tomembranes, and probed for biotin with streptavidin-conjugated alkaline
yield an 18-kDa species, the data suggest that whenphosphatase. The high-mannose carbohydrate form of CM2AA and
CM2 is expressed either in influenza C virus-infectedCM2AAtag as well as the corresponding glycosylation minus mutants
were all biotinylated, indicating expression at the cell surface. MDCK cells or from cDNA in HeLa-T4 and CV-1 cells
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M2 and NB proteins use their single hydrophobic domain
both to target the protein to the membrane of the ER and
to bring about their stable integration in the membrane.
It is tempting to speculate that CM2 has an ion channel
activity, as has been firmly established for influenza A
virus M2 protein, and preliminary experiments indicate
that influenza B virus NB protein may also have an ion
channel activity (reviewed in Lamb and Pinto, 1997). Fur-
thermore, a strong case can be made for an ion channel
activity in the life cycles of influenza A and B viruses
(reviewed in Lamb and Pinto, 1997). A priori, the require-
ment for an ion channel activity in influenza C virus un-
coating is not pressing because in vitro, dissociation of
the nucleocapsid from the M protein occurs at neutral to
mildly alkali pH (Zhirnov and Grigoriev, 1994), unlike the
situation for influenza A and B viruses which require
acidic pH (Zhirnov, 1992). However, little is known about
the transport of the influenza C virus HEF glycoproteinFIG. 11. Influenza A, B, and C viruses encode small integral mem-
brane proteins with analogous structural features. The three proteins through the acidic lumen of the TGN, and even though
differ in their coding strategies, in their carbohydrate modifications HEF is not cleaved intracellularly, transport of HEF in a
(ovals), and in the presence of a signal peptide. The mature proteins fusion-competent form to the cell surface may require
are similar, however, in their orientation and size. The number of amino
equilibration of pH between the lumen of the TGN andacids in each domain is indicated.
the cytoplasm because in some studies it has been found
that HEF expressed from cDNA is poorly expressed at
the cell surface (Pleschka et al., 1995; Szepanski et al.,using the vac-T7 expression system, the high-mannose
chains are further modified by the addition of polylacto- 1994). In this regard we were interested to observe that
increasing expression levels of CM2 reduced the addi-saminoglycan. It is possible that the inability to digest
the heterogenous carbohydrate on CM2 when it was tion of polylactosaminoglycan modification to CM2. At
the present time we do not know if the reduction in poly-expressed in HMV-II cells with endo b (Hongo et al.,
1997) occurs because in this cell line the carbohydrate lactosaminoglycan modification to CM2 upon increasing
expression level is due to saturation of the glycosylationchains are highly branched or terminally modified, mak-
ing endo b digestion difficult. It is interesting to note machinery, due to saturation of the transport machinery,
or due to a biological effect of CM2 expression on thethat polylactosaminoglycan modification of carbohydrate
chains is particularly prevalent on small integral mem- TGN. We had observed previously that increased expres-
sion of a glycosylated derivative of influenza A virus M2brane proteins with a membrane proximal glycosylation
site (e.g., a membrane-anchored form of rat growth hor- protein (gM2), which had a functional ion channel activity,
caused reduced addition of polylactosaminoglycans tomone, influenza B virus NB glycoprotein, respiratory syn-
cytial virus SH protein, and a modified form of influenza gM2 and this alteration in glycosylation could be reversed
by addition of the M2 ion channel blocker, amantadineA virus M2 protein into which a glycosylation site had
been engineered) (Guan et al., 1985; Olmsted and Col- (Sakaguchi et al., 1996). We had also observed previously
that an increasing gradient of influenza A virus M2 proteinlins, 1989; Sakaguchi et al., 1996; Williams and Lamb,
1986; 1988). However, ablation of the carbohydrate addi- expression progressively reduced cleavage and cell sur-
face expression of coexpressed influenza A virus HA duetion to CM2 did not prevent CM2 from forming disulfide-
linked dimers and tetramers nor did it prevent expression to equilibration of pH between the TGN and the cyto-
plasm (Sakaguchi et al., 1996). In this regard it is alsoof CM2 at the cell surface. Thus, glycosylation of CM2
probably does not occur during folding and oligomeriza- interesting to note that an increasing gradient of CM2
expression progressively reduced cell surface expres-tion, which is in contrast to the situation found with many
larger integral membrane proteins (reviewed in Doms et sion of coexpressed HEF (our unpublished observation).
Thus, there are interesting parallels in the structural or-al., 1993).
The NoutCin membrane orientation of CM2 and the size ganization and in some biological properties of CM2 and
influenza A virus M2 protein which require further investi-of the ectodomain and cytoplasmic tail of CM2 plus its
ability to form disulfide-linked oligomers are reminiscent gation.
It will also be interesting to determine the mechanismof properties of influenza A virus M2 and influenza B virus
NB proteins (Fig. 11). The major difference between CM2 by which initiation of protein synthesis for CM2 occurs.
We have observed that transfection of equal amounts ofand M2 and NB proteins is that the available data indicate
that CM2 has a cleavable signal sequence whereas both plasmid DNA encoding the complete RNA segment 6
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Kozak, M. (1989). The scanning model for translation: An update. J. CellORF or the CM2 ORF causes the accumulation of similar
Biol. 108, 229–241.amounts of CM2 protein after a 15-min pulse label (our
Lamb, R. A., Holsinger, L. J., and Pinto, L. H. (1994). The influenza A
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somes, rather than scanning from the 5* end of the large cycle. In ‘‘Receptor-Mediated Virus Entry into Cells’’ (E. Wimmer, Ed.),
pp. 303–321. Cold Spring Harbor Laboratory Press, Cold Spring Har-ORF, are capable of internal entry 5* proximal to the AUG
bor, NY.codon at nucleotide 731, and this hypothesis is amenable
Lamb, R. A., and Krug, R. M. (1996). Orthomyxoviridae: The viruses andto direct experimentation.
their replication. In ‘‘Virology’’ (B. N. Fields, D. M. Knipe, and P. M.
Howley, Eds.), 3rd ed., pp. 1353–1394. Raven Press, New York.
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